Skip to main content
Erschienen in: Surgical Endoscopy 10/2013

01.10.2013

Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature

verfasst von: Mark R. Wendling, W. Scott Melvin, Kyle A. Perry

Erschienen in: Surgical Endoscopy | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Gastroesophageal reflux disease (GERD) remains a significant problem for the medical community. Many endoluminal treatments for GERD have been developed with little success. Currently, transoral incisionless fundoplication (TIF) attempts to recreate a surgical fundoplication through placement of full-thickness polypropylene H-fasteners. This, the most recent procedure to gain FDA approval, has shown some promise in the early data. However, questions of its safety profile, efficacy, and durability remain.

Methods

The Cochrane Library and MEDLINE through PubMed were searched to identify published studies reporting on subjective and objective GERD indices after TIF. The search was limited to human studies published in English from 2006 up to March 2012. Data collected included GERD-HRQL and RSI scores, PPI discontinuation and patient satisfaction rates, pH study metrics, complications, and treatment failures. Statistical analysis was performed with weighted t tests.

Results

Titles and abstracts of 214 papers were initially reviewed. Fifteen studies were found to be eligible, reporting on over 550 procedures. Both GERD-HRQL scores (21.9 vs. 5.9, p < 0.0001) and RSI scores (24.5 vs. 5.4, p ≤ 0.0001) were significantly reduced after TIF. Overall patient satisfaction was 72 %. The overall rate of PPI discontinuation was 67 % across all studies, with a mean follow-up of 8.3 months. pH metrics were not consistently normalized. The major complication rate was 3.2 % and the failure rate was 7.2 % across all studies.

Conclusion

TIF appears to provide symptomatic relief with reasonable levels of patient satisfaction at short-term follow-up. A well-designed prospective clinical trial is needed to assess the effectiveness and durability of TIF as well as to identify the patient population that will benefit from this procedure.
Literatur
1.
Zurück zum Zitat American Gastroenterological Association (2001) The Burden of gastrointestinal diseases. AGA, Bethesda, pp 18–21 American Gastroenterological Association (2001) The Burden of gastrointestinal diseases. AGA, Bethesda, pp 18–21
2.
Zurück zum Zitat Moayyedi P, Leontiadis GI (2012) The risks of PPI therapy. Nat Rev Gastroenterol Hepatol 9:132–139PubMedCrossRef Moayyedi P, Leontiadis GI (2012) The risks of PPI therapy. Nat Rev Gastroenterol Hepatol 9:132–139PubMedCrossRef
3.
Zurück zum Zitat Linsky A, Gupta K, Lawler EV et al (2010) Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 170:772–778PubMedCrossRef Linsky A, Gupta K, Lawler EV et al (2010) Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 170:772–778PubMedCrossRef
4.
Zurück zum Zitat Howell MD, Novack V, Grgurich P et al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170:784–790PubMedCrossRef Howell MD, Novack V, Grgurich P et al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170:784–790PubMedCrossRef
5.
Zurück zum Zitat Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 326:786–792PubMedCrossRef Spechler SJ (1992) Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 326:786–792PubMedCrossRef
6.
Zurück zum Zitat Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701PubMedCrossRef Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701PubMedCrossRef
7.
Zurück zum Zitat Barnes WE, Hoddinott KM, Mundy S et al (2011) Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 18:119–129PubMedCrossRef Barnes WE, Hoddinott KM, Mundy S et al (2011) Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 18:119–129PubMedCrossRef
8.
Zurück zum Zitat Bell RC, Freeman KD (2011) Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc 25:1975–1984PubMedCrossRef Bell RC, Freeman KD (2011) Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc 25:1975–1984PubMedCrossRef
9.
Zurück zum Zitat Cadiere GB, Buset M, Muls V et al (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676–1688PubMedCrossRef Cadiere GB, Buset M, Muls V et al (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676–1688PubMedCrossRef
10.
Zurück zum Zitat Cadiere GB, Van Sante N, Graves JE et al (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. Surg Endosc 23:957–964PubMedCrossRef Cadiere GB, Van Sante N, Graves JE et al (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX. Surg Endosc 23:957–964PubMedCrossRef
11.
Zurück zum Zitat Demyttenaere SV, Bergman S, Pham T et al (2010) Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Surg Endosc 24:854–858PubMedCrossRef Demyttenaere SV, Bergman S, Pham T et al (2010) Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population. Surg Endosc 24:854–858PubMedCrossRef
12.
Zurück zum Zitat Frazzoni M, Conigliaro R, Manta R et al (2011) Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 34:67–75PubMedCrossRef Frazzoni M, Conigliaro R, Manta R et al (2011) Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 34:67–75PubMedCrossRef
13.
Zurück zum Zitat Hoppo T, Immanuel A, Schuchert M et al (2010) Transoral incisionless fundoplication 2.0 procedure using EsophyX for gastroesophageal reflux disease. J Gastrointest Surg 14:1895–1901PubMedCrossRef Hoppo T, Immanuel A, Schuchert M et al (2010) Transoral incisionless fundoplication 2.0 procedure using EsophyX for gastroesophageal reflux disease. J Gastrointest Surg 14:1895–1901PubMedCrossRef
14.
Zurück zum Zitat Ihde GM, Besancon K, Deljkich E (2011) Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 202:740–746 discussion 746–747PubMedCrossRef Ihde GM, Besancon K, Deljkich E (2011) Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surg 202:740–746 discussion 746–747PubMedCrossRef
15.
Zurück zum Zitat Narsule CK, Burch MA, Ebright MI et al (2012) Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience. J Thorac Cardiovasc Surg 143:228–234PubMedCrossRef Narsule CK, Burch MA, Ebright MI et al (2012) Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience. J Thorac Cardiovasc Surg 143:228–234PubMedCrossRef
16.
Zurück zum Zitat Nguyen A, Vo T, Nguyen XM et al (2011) Transoral incisionless fundoplication: initial experience in patients referred to an integrated academic institution. Am Surg 77:1386–1389PubMed Nguyen A, Vo T, Nguyen XM et al (2011) Transoral incisionless fundoplication: initial experience in patients referred to an integrated academic institution. Am Surg 77:1386–1389PubMed
17.
Zurück zum Zitat Petersen RP, Filippa L, Wassenaar EB et al (2012) Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device. Surg Endosc 26(4):1021–1027PubMedCrossRef Petersen RP, Filippa L, Wassenaar EB et al (2012) Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device. Surg Endosc 26(4):1021–1027PubMedCrossRef
18.
Zurück zum Zitat Repici A, Fumagalli U, Malesci A et al (2010) Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg 14:1–6PubMedCrossRef Repici A, Fumagalli U, Malesci A et al (2010) Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience. J Gastrointest Surg 14:1–6PubMedCrossRef
19.
Zurück zum Zitat Testoni PA, Vailati C, Testoni S et al (2012) Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc 26(5):1425–1435PubMedCrossRef Testoni PA, Vailati C, Testoni S et al (2012) Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc 26(5):1425–1435PubMedCrossRef
20.
Zurück zum Zitat Trad KS, Turgeon DG, Deljkich E (2012) Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 26:650–660PubMedCrossRef Trad KS, Turgeon DG, Deljkich E (2012) Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Surg Endosc 26:650–660PubMedCrossRef
21.
Zurück zum Zitat Velanovich V (2010) Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery 148:646–651 discussion 651-643PubMedCrossRef Velanovich V (2010) Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery 148:646–651 discussion 651-643PubMedCrossRef
22.
Zurück zum Zitat Hunter J, Trus T, Branum G et al (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673–685PubMedCrossRef Hunter J, Trus T, Branum G et al (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673–685PubMedCrossRef
23.
Zurück zum Zitat Testoni PA, Corsetti M, Di Pietro S et al (2010) Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 34:750–757PubMedCrossRef Testoni PA, Corsetti M, Di Pietro S et al (2010) Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg 34:750–757PubMedCrossRef
24.
Zurück zum Zitat Khajanchee YS, Ujiki M, Dunst CM et al (2009) Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD. Surg Endosc 23:2525–2530PubMedCrossRef Khajanchee YS, Ujiki M, Dunst CM et al (2009) Patient factors predictive of 24-h pH normalization following endoluminal gastroplication for GERD. Surg Endosc 23:2525–2530PubMedCrossRef
25.
Zurück zum Zitat Bergman S, Mikami DJ, Hazey JW et al (2008) Endolumenal fundoplication with EsophyX: the initial North American experience. Surg Innov 15:166–170PubMedCrossRef Bergman S, Mikami DJ, Hazey JW et al (2008) Endolumenal fundoplication with EsophyX: the initial North American experience. Surg Innov 15:166–170PubMedCrossRef
26.
Zurück zum Zitat Rantanen TK, Salo JA, Sipponen JT (1999) Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 86:1573–1577PubMedCrossRef Rantanen TK, Salo JA, Sipponen JT (1999) Fatal and life-threatening complications in antireflux surgery: analysis of 5,502 operations. Br J Surg 86:1573–1577PubMedCrossRef
27.
Zurück zum Zitat Bell RC, Cadiere GB (2011) Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc 25:2387–2399PubMedCrossRef Bell RC, Cadiere GB (2011) Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc 25:2387–2399PubMedCrossRef
Metadaten
Titel
Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature
verfasst von
Mark R. Wendling
W. Scott Melvin
Kyle A. Perry
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 10/2013
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-013-2961-0

Weitere Artikel der Ausgabe 10/2013

Surgical Endoscopy 10/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.